Key result
Poliomyelitis antistreptococcus serum was discussed as a potential treatment for acute poliomyelitis, but the incomplete abstract reports no quantitative efficacy or safety outcomes.
Why the study?
Does poliomyelitis antistreptococcus serum improve outcomes in patients with acute poliomyelitis?
Population
Patients with acute poliomyelitis
Authors
Loading...
Hypothesis-generating for poliomyelitis antistreptococcus serum in acute disease; controlled trials needed before any clinical consideration.
Does poliomyelitis antistreptococcus serum improve outcomes in patients with acute poliomyelitis?
The abstract discusses the potential value of poliomyelitis antistreptococcus serum in treating acute poliomyelitis based on personal observations and previous reports.
Edward C. Rosenow (1927) studied Acute poliomyelitis. Poliomyelitis antistreptococcus serum was evaluated. Poliomyelitis antistreptococcus serum was discussed as a potential treatment for acute poliomyelitis, but the incomplete abstract reports no quantitative efficacy or safety outcomes.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: